Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Carrie Langstraat"'
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101425- (2024)
Objectives: Patients with class 3 obesity (BMI ≥ 40) and significant medical comorbidities with complex atypical hyperplasia (CAH) and early-stage endometrial cancer (EC) present challenges in standard surgical management. Progestin therapy is an a
Externí odkaz:
https://doaj.org/article/d1241d1890644485a2a81265aff1e471
Autor:
Maryam Shahi, Levon Katsakhyan, Mark Hopkins, Wendy Allen-Rhoades, Marissa K. Cepress, Carrie Langstraat, Michael B. Ishitani, Russell Vang, Brigitte M. Ronnett, Deyin Xing
Publikováno v:
Diagnostic Pathology, Vol 19, Iss 1, Pp 1-7 (2024)
Abstract We previously described a series of cases which characterize a distinct group of primary ovarian placental site trophoblastic tumor (PSTT) and epithelioid trophoblastic tumor (ETT) as a non-gestational set consistent with germ cell type/orig
Externí odkaz:
https://doaj.org/article/ac01fc4e7cf548029fe08e2254e6b562
Autor:
Aparna Kailasam, Giuseppe Cucinella, Angela J Fought, William Cliby, Andrea Mariani, Gretchen Glaser, Carrie Langstraat
Publikováno v:
Gynecologic Oncology Reports, Vol 50, Iss , Pp 101280- (2023)
Objective: Nonsurgical management for endometrial cancer in patients with class 3 obesity (BMI ≥ 40 kg/m2) is a challenging scenario given lack of consensus on patient selection and treatment options. Our objective was to evaluate trends in practic
Externí odkaz:
https://doaj.org/article/90c3cb64986e47fc9e209e53f73c0215
Publikováno v:
Gynecologic Oncology Reports, Vol 39, Iss , Pp 100923- (2022)
Non-gestational choriocarcinoma is a rare and aggressive germ cell tumor. Here we present the case of a post-menopausal 49-year-old woman who presented with metastatic disease and initially achieved a complete radiographic and biomarker response with
Externí odkaz:
https://doaj.org/article/7892a6384fb943bbb3801ffa1b53894f
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss , Pp 100731- (2021)
Prehabilitation may modify frailty and increase resilience in a subset of ovarian cancer patients; however there is low adherence to most programs. Our aim was to investigate potential barriers and facilitators of prehabilitation during neoadjuvant c
Externí odkaz:
https://doaj.org/article/8b42209c054442babf5025222d10c66a
Publikováno v:
Infectious Diseases in Obstetrics and Gynecology, Vol 2006 (2006)
Objectives. Our aim is evaluating the need for repeating tests for syphilis on pregnant women in the third trimester. Study design. A single-center retrospective cohort study was performed on all women delivering 7/03–6/04. Results. During the stud
Externí odkaz:
https://doaj.org/article/c92e788af11f4c74b991e74c585c531b
Autor:
Arwa Mohammad, Chiara Ainio, Deepa Maheswari Narasimhulu, Michaela McGree, Amy L Weaver, Amanika Kumar, Annalisa Garbi, Andrea Mariani, Giovanni Aletti, Francesco Multinu, Carrie Langstraat, William Cliby
Publikováno v:
International Journal of Gynecologic Cancer. 33:727-733
ObjectiveTo compare the ability of current complication reporting scales (Contracted Accordion Scale, Expanded Accordion Scale, Clavien-Dindo Scale) to reflect the severity of patient outcomes after cytoreductive surgery for ovarian cancer.MethodsWe
Autor:
Deepa Maheswari Narasimhulu, Anna Fagotti, Giovanni Scambia, Amy L Weaver, Michaela McGree, Lorena Quagliozzi, Carrie Langstraat, Amanika Kumar, William Cliby
Publikováno v:
Int J Gynecol Cancer
ObjectiveWe developed an algorithm that identifies patients at high risk of morbidity/mortality after cytoreductive surgery for advanced ovarian cancer. We have previously shown that the Mayo triage algorithm reduces operative mortality internally, f
Autor:
Aparna Kailasam, Carrie Langstraat
Publikováno v:
Current treatment options in oncologyReferences and Recommended ReadingPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 23(12)
Most endometrial cancers are estrogen receptor and progesterone receptor positive. Hormonal therapy in endometrial cancer is best used in patients with low-grade disease and hormone receptor positivity. Though not standard of care, hormonal treatment
Autor:
Gabriella Schivardi, Giuseppe Cucinella, Andrea Mariani, Maryam Shahi, Carrie Langstraat, Amy Weaver, Michaela Mc Gree, Francesco Multinu, Vanna Zanagnolo, Ilaria Betella, Glauco Baiocchi, Louise de Brot, Robert Giuntoli, Spyridon Mastroyannis, Gretchen Glaser
Publikováno v:
Endometrial cancer.